Picture of Mycelx Technologies logo

MYX — Mycelx Technologies News Story

0.000.00%
gb flag iconLast trade - 00:00
IndustrialsSpeculativeMicro CapNeutral

MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing

RNS Number : 6532J

MyCelx Technologies Corporation

21 May 2025

 

21 May 2025

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Director Dealing

 

The Company announces that it was notified by Connie Mixon, Chief Executive Officer and Director of the Company, that on 21 May 2025, she purchased 73,500 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.26415 per Common Share. Following this transaction, Mrs. Mixon holds 2,776,068 Common Shares representing 11.39 per cent of the total issued capital of the Company. In addition, the spouse of Mrs. Mixon also holds 229,008 shares in the Company.

 

 

For further information please contact:

 

MYCELX Technologies Corporation
Connie Mixon, CEO
Kim Slayton, CFO
Tel: +1 888 306 6843
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)
Giles Balleny (Corporate Finance)
Jamie Anderson (Corporate Broking)
Jasper Berry / Michael Johnson (Sales)
Tel: +44 20 7523 8000
Celicourt Communications (Financial PR)
Mark Antelme
Jimmy Lea
Charlie Denley-Myerson
Tel: +44 20 2770 6424
  Notification of transactions of persons discharging managerial responsibility or connected persons
1Details of the person discharging managerial responsibilities / person closely associated
a)NameConnie Mixon
2Reason for the notification
a)Position/statusChief Executive Officer and Director
b)Initial notification /AmendmentInitial notification
3Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)NameMYCELX Technologies Corporation
b)LEI213800UJZINIK2VD1G48
4Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)Description of the financial instrument, type of instrumentCommon shares of US$0.025
ISIN: US62847T2024
b)Nature of the transactionPurchase of Common Shares in GBP
c)Price(s) and volume(s)
Price(s)Volume(s)
£0.2641573,500
d)Aggregated information
- Aggregated volume
- Price
n/a
n/a
e)Date of the transaction21/05/2025
f)Place of the transactionLondon Stock Exchange(AIM)
  This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.   END     DSHFLFFSEVILFIE

Recent news on Mycelx Technologies

See all news